Parker-Hannifin CorpPH
Parker-Hannifin Corp Financial Overview 2021–2025
Updated Jul 10, 2026Parker-Hannifin’s operating cash flow surged to a record $3.8 billion by the close of FY2025, giving the industrial giant immense firepower to execute massive acquisitions without fracturing its balance sheet. By consolidating the global aerospace market while stripping out redundant costs, the company has transformed into a high-margin compounding machine. This strategic pivot is most visible on the bottom line, where earnings per share more than doubled from $13.35 in FY2021 to $27.12 in FY2025.
The successful $7.2 billion integration of Meggitt fundamentally altered the company's trajectory, pushing total revenue to $19.9 billion in FY2024 and swelling the forward backlog to $11.0 billion by the end of FY2025. Disciplined pricing power and cost containment further amplified these top-line gains, driving a 36.8% gross profit margin during Q1 2025. Management simultaneously redirected this robust cash generation back to shareholders, executing $1.6 billion in stock buybacks during FY2025 alone and maintaining a 69-year streak of annual dividend increases to reach a $7.20 annual rate. The equity market heavily rewarded this operational execution; at the close of FY2025, Parker-Hannifin traded at $698.47 per share, commanding a 25.8x earnings multiple as investors priced in the company's expanding aerospace dominance.
Recent Developments (Q2 and Q3 2026)
Parker-Hannifin accelerated its portfolio expansion during Q2 2026 and Q3 2026 with the announced $9.25 billion acquisition of Filtration Group and the completed $1.0 billion purchase of Curtis Instruments. Operational execution remained strong for the nine months ended March 31, 2026, as net sales reached $15.74 billion, up from $14.61 billion the prior year. Over the same period, operating income grew to $3.75 billion, while total backlog climbed to $12.5 billion. On the governance front, board director Kevin A. Lobo announced he will step down at the 2026 annual meeting to join GE HealthCare.
Bulls see this robust backlog and strategic M&A pipeline driving sustained top-line acceleration across key industrial segments. Conversely, bears note the equity appears richly valued at 32.5x earnings as of May 1, 2026, raising concerns over increased leverage and balance sheet risk tied to the pending Filtration Group purchase.
What to watch: integration milestones and debt financing for the Filtration Group acquisition; margin resilience amid ongoing material cost pressures.
Rev
$19.85B
FY2025
NI
$3.53B
FY2025
EPS
$27.52
FY2025
OCF
$3.78B
FY2025
Year-over-year comparison from 10-K annual reports
Data from SEC Company Facts
Recent SEC Filings
Parker-Hannifin Corp 8-K Report, Financial Results (Apr 30, 2026)
Parker-Hannifin Corporation (PH) filed an 8-K on April 30, 2026, primarily to furnish a press release detailing its financial results for the third quarter of fiscal year 2026, which ended on March 31, 2026. This filing serves as the primary vehicle for investors to access the company's latest operational and financial performance data. While the 8-K itself does not contain the detailed financial tables, it directs investors to the accompanying press release (Exhibit 99.1) for comprehensive figures and management commentary. Investors should review the furnished press release for key metrics such as revenue, earnings per share (EPS), segment performance, and any forward-looking guidance provided by the company. This information is crucial for assessing the company's current financial health, operational efficiency, and future prospects in the industrial and motion-control sectors. The filing also includes the standard Interactive Data File for enhanced analysis.
Parker-Hannifin Corp 8-K Report, Executive Changes (Mar 17, 2026)
This 8-K filing from Parker-Hannifin Corporation (PH) reports the upcoming departure of a long-standing board member, Kevin A. Lobo. Mr. Lobo, who has served on the board since 2013, has decided not to stand for reelection at the upcoming 2026 Annual Meeting of Shareholders. This decision is attributed to his election to the Board of Directors of GE HealthCare Technologies Inc., indicating a potential reallocation of his time and focus to his new role. Importantly, the filing explicitly states that Mr. Lobo's decision is not due to any disagreements with Parker-Hannifin regarding its operations, policies, or practices. Investors can take comfort in knowing that this change appears to be driven by Mr. Lobo's increased commitments elsewhere, rather than any internal company issues. Mr. Lobo is expected to continue his service as a director until the end of his current term, ensuring a smooth transition.
Parker-Hannifin Corp 8-K Report, Financial Results (Jan 29, 2026)
Parker-Hannifin Corporation (PH) has filed an 8-K to report on its financial results for the quarter ended December 31, 2025. The key information is contained within the press release furnished as Exhibit 99.1, which details the company's performance during the second fiscal quarter of 2026. Investors should refer to this press release for specific financial metrics, operational updates, and forward-looking statements. While this 8-K filing itself is procedural, it signals the availability of crucial earnings information. The press release will likely contain details on revenue, profitability, segment performance, and management's commentary on market conditions and strategic initiatives. Investors are advised to examine the furnished press release for a comprehensive understanding of Parker-Hannifin's current financial health and outlook.
Parker-Hannifin Corp 8-K Report, Material Agreement (Dec 10, 2025)
Parker-Hannifin Corporation (PH) has announced the establishment of significant new credit facilities to finance a portion of its proposed acquisition of Filtration Group Corporation. On December 10, 2025, the company entered into two agreements: a $5.25 billion 364-day term loan facility with Barclays Bank PLC and a $2.50 billion three-year term loan facility with KeyBank National Association. These unsecured, delayed draw facilities collectively provide up to $7.75 billion in committed financing, underscoring the substantial capital required for the Filtration Group acquisition. The terms include customary covenants, events of default, and interest based on SOFR plus an applicable margin tied to the company's credit ratings.
Parker-Hannifin Corp 8-K Report, Material Agreement (Nov 12, 2025)
Parker-Hannifin Corporation (PH) has announced a significant strategic move by entering into a definitive agreement to acquire Filtration Group Corporation for $9.25 billion in cash, on a cash-free, debt-free basis. This acquisition, expected to be financed through new debt and existing cash, positions Parker-Hannifin to enhance its filtration technologies portfolio, particularly for critical applications. The deal is subject to customary closing conditions, including regulatory approvals such as the Hart-Scott-Rodino Act, and is anticipated to close by February 10, 2027, with potential extensions. This transaction represents a substantial investment for Parker-Hannifin and underscores a commitment to growth through strategic acquisitions. Investors should monitor the progress of regulatory approvals and the integration process post-closing, as the successful realization of synergies and value creation will be key determinants of the acquisition's long-term success. The company has provided a cautionary note regarding forward-looking statements, highlighting potential risks and uncertainties associated with the merger, including integration challenges, regulatory hurdles, and the possibility of the transaction not closing.
View all 8-K filings →